SPECIAL NOTICE
65 -- Wetvax Potency Testing 2022
- Notice Date
- 4/26/2022 11:50:28 AM
- Notice Type
- Special Notice
- NAICS
- 325412
— Pharmaceutical Preparation Manufacturing
- Contracting Office
- ASPR OFFICE OF THE ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE Washington DC 20201 USA
- ZIP Code
- 20201
- Solicitation Number
- 75A50322Q00016
- Response Due
- 5/3/2022 11:00:00 AM
- Point of Contact
- Alise Taylor-Sindab
- E-Mail Address
-
sut4@cdc.gov
(sut4@cdc.gov)
- Description
- The purpose of this requirement is to perform potency testing using an FDA qualified and validated vaccinia-based potency assay on samples of Wetvax provided by the ASPR/SNS. The following technical specifications are necessary to fulfill this requirement: The vendor must have an FDA qualified and validated vaccinia virus potency test which is currently being used to titer the potency of all current lots of the ACAM2000 Smallpox vaccine. � The vendor shall test must be identical to the requirements outlined in protocol currently being used by Emergent BioDefense Operations Lansing, LLC, Canton, MA.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/d26de2798d664d0c833bf995ea191beb/view)
- Record
- SN06307817-F 20220428/220426230109 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |